Combination with other agents might allow dose reduction of the GLP-1 component
Across ten studies of GLP-1 receptor agonists and dual glucose-dependent insulinotropic polypeptide (GIP) agonists, caloric intake was reduced by approximately 1639 % compared to placebo [16]
While it might not be the most glamorous topic, paying attention to these changes provides valuable feedback on how to adjust your fiber intake for optimal digestive health
Branded products add probiotic strains, metabolic compounds, and digestive enzymes, some with published ingredient-level research, some without, at 3-6x the cost of generic fiber
Trials require effective contraception
Postoperative aspiration pneumonia among adults using GLP-1 receptor agonists